🔎 Trials Near Me

Akèy › Leksemi limfoblastik egi › Tennessee › Nashville

Etid klinik pou Leksemi limfoblastik egi nan Nashville, TN

8 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Ap rekriteFaz 2
  • TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
6 Months · Tout sèks · Mizajou Sep 28, 2026 · NCT06514794

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Ap rekriteFaz 1/2
  • The Children's Hospital at TriStar Centennial, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241

A Study of CTD402 in T-ALL/LBL Patients

Ap rekriteFaz 1/2
  • Sarah Cannon Research Insitute, Nashville
Laj 1 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Ap rekriteEtid obsèvasyon
  • Vanderbilt University Medical Center, Nashville
1 Day – 17 Years · Tout sèks · Mizajou Aug 14, 2026 · NCT06274788

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Ap rekriteFaz 1/2
  • Research Site, Franklin · 17 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT07109219

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Vanderbilt University, Nashville
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • TriStar Centennial Medical Center, Nashville
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

HPC Offered for PRESERVE Expansion

Ap rekriteEtid obsèvasyon
  • Tristar Centennial Medical Center, Nashville
Laj 12 a 80 · Tout sèks · Mizajou Aug 28, 2025 · NCT07145411

Etid Leksemi limfoblastik egi nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.